Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) is gaining momentum, as company announces multibillion-dollar deal to buy cardio-focused biopharmaceutical Myokardia Inc (NASDAQ: MYOK)
CAMEROON MAGAZINE - GM05/10/20201 Mins read119 ViewsLe défi de ChatGPT en tant que conseiller financier Dans le cadre...
ByCAMEROON MAGAZINE - GM30/06/2023Berenberg Bank a réduit son objectif de cours sur Bristol-Myers Squibb de...
ByCAMEROON MAGAZINE - GM11/10/2021It is the time of year when ideas are constantly coming up...
ByCAMEROON MAGAZINE - GM09/11/2020This is the second Houston police officer to be killed by fire...
ByCAMEROON MAGAZINE - GM09/11/2020